Covaxin and Covishield are two different COVID-19 vaccines that have been developed to help protect against the SARS-CoV-2 virus, which causes COVID-19. They have some differences in terms of their development, composition, and administration:
- Development:
-
- Covaxin: Covaxin, also known as Bharat Biotech’s Covaxin or BBV152, is an inactivated virus vaccine. It was developed by Bharat Biotech, an Indian pharmaceutical company, in collaboration with the Indian Council of Medical Research (ICMR). Covaxin involves using inactivated or “killed” SARS-CoV-2 virus particles to stimulate an immune response.
- Covishield: Covishield is the trade name for the Oxford-AstraZeneca COVID-19 vaccine manufactured by the Serum Institute of India. It is based on a viral vector platform and uses a modified chimpanzee adenovirus (ChAdOx1) to deliver genetic material that encodes a part of the SARS-CoV-2 spike protein to trigger an immune response.
- Composition:
-
- Covaxin: Covaxin contains inactivated SARS-CoV-2 virus particles, and it does not contain any live virus. It also includes additional components to enhance the immune response.
- Covishield: Covishield is a viral vector vaccine that uses a non-replicating adenovirus vector to deliver genetic material, rather than containing inactivated virus particles.
- Efficacy and Approval:
-
- Both vaccines have undergone clinical trials to determine their safety and efficacy. Covaxin and Covishield have been approved for emergency use in India and other countries. The efficacy rates reported in clinical trials may vary, but both vaccines have demonstrated effectiveness in reducing the risk of COVID-19 infection and its severity.
- Storage and Handling:
-
- Covaxin generally requires storage at standard refrigeration temperatures, making it relatively easier to distribute and administer.
- Covishield can typically be stored at standard refrigeration temperatures as well, but it may have specific temperature requirements depending on the manufacturer’s guidelines.
- Administration:
-
- Both vaccines are administered through intramuscular injections.
- The dosing schedule may vary depending on the vaccine and region, so individuals receiving these vaccines should follow the guidance provided by health authorities.
It’s important to note that the availability and recommendations for COVID-19 vaccines may change over time, and new vaccines may become available. It is essential to consult with healthcare professionals and follow the guidance of local health authorities regarding COVID-19 vaccination, including which vaccine is recommended for specific populations and regions.